RECRUITING

Validating Incubators in the Lab: Optimizing Culture and Investigating blasTulation Yield

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this study is to determine if benchtop incubators improve the number of embryos making it to the blastocyst stage of development (about 4-6 days after fertilization) in people undergoing in vitro fertilization (IVF) treatment for their infertility. * Test the effectiveness of the benchtop incubator. * Determine if the number of embryos reaching the blastocyst stage of embryo development (the stage that the embryos are biopsied for PGT-A and frozen) is improved in the benchtop incubator compared to the box incubator. * Compare embryology outcomes between the two incubator types. * Investigate transfer and pregnancy outcomes. * Expand the knowledge surrounding the impact of the incubator on IVF outcomes. Patients will have their mature oocytes collected at the egg retrieval procedure split into two groups and randomized to be cultured in both incubator types.

Official Title

The VILOCITY Trial: Validating Incubators in the Lab: Optimizing Culture and Investigating blasTulation Yield: a Randomized Control Trial (RCT)

Quick Facts

Study Start:2023-12-19
Study Completion:2026-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06214936

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 41 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Caroline Zuckerman, BS, RN
CONTACT
19736562841
clinicalresearchteam@ivirma.com
Christine V Whitehead, BSN, RN
CONTACT
19736562841
clinicalresearchteam@ivirma.com

Principal Investigator

Thomas Molinaro, MD, MSCE
PRINCIPAL_INVESTIGATOR
Reproductive Medicine Associates of New Jersey

Study Locations (Sites)

Reproductive Medicine Associates of New Jersey
Basking Ridge, New Jersey, 07920
United States

Collaborators and Investigators

Sponsor: Reproductive Medicine Associates of New Jersey

  • Thomas Molinaro, MD, MSCE, PRINCIPAL_INVESTIGATOR, Reproductive Medicine Associates of New Jersey

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-12-19
Study Completion Date2026-06

Study Record Updates

Study Start Date2023-12-19
Study Completion Date2026-06

Terms related to this study

Additional Relevant MeSH Terms

  • Infertility